Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer

Eitemau Tebyg

• Serial assessment of circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapy
  gan: Wang, Xiaoli, et al.
  Cyhoeddwyd: (2021)
• Infiltration of metastatic lymph nodes with PD-1(+) T cells is associated with improved disease-free and overall survival in resected N(+) NSCLC
  gan: Wang, Shuo, et al.
  Cyhoeddwyd: (2020)
• Clinical efficacy of intra-cavitary infusions of autologous dendritic cell/cytokine-induced killer cell products for the treatment of refractory malignant pleural effusions and ascites
  gan: He, Zixuan, et al.
  Cyhoeddwyd: (2020)
• Expression of Lymphocyte-Activation Gene 3 (LAG-3) Immune Checkpoint Receptor Identifies a Tumor-Reactive T Cell Population in the Peripheral Blood of Patients with Colorectal Cancer
  gan: Huang, Lefu, et al.
  Cyhoeddwyd: (2019)
• Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy
  gan: Ren, Jun, et al.
  Cyhoeddwyd: (2016)